CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Fate Therapeutics Inc Company Snapshot
Fate Therapeutics Inc operates in the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Fate Therapeutics Inc with three other companies in this sector in the United States: Pluristem Therapeutics Incorporation. (2016 sales of $2.85 million of which 100% was Stem Cells Expansion), Oncobiologics Inc ($2.98 million ), and BioTime, Inc. ($5.92 million of which 100% was Synthetic Solutions).

Sales Analysis.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Fate Therapeutics Inc
  Stock Performance Chart for Fate Therapeutics Inc
 
  Stock Data: Recent Stock Performance:
  Current Price (3/24/2017): 4.77
(Figures in U.S. Dollars)
1 Week -3.6%   13 Weeks 17.2%  
4 Weeks 68.6%   52 Weeks 153.7%  
 
Fate Therapeutics Inc Key Data:
  Ticker: FATE Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2016 Sales 4,402,000
(Year Ending Jan 2017).
Employees: 60
  Currency: U.S. Dollars Market Cap: 197,413,634
  Fiscal Yr Ends: December Shares Outstanding: 41,386,506
  Share Type: Common Closely Held Shares: 846,223
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.